Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Dexmedetomidine on Post-operative Narcotic Requirements and Pain Scores in Bariatric Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be undergoing open bariatric surgery at WVUH-ruby hospital. - They must be ASA class 1, 2 and 3.~* Consented individuals.~* They must be between the age of 18 to 55.~Exclusion Criteria:~* History of bradycardia or tachy-brady syndrome HR\<45.~* 1st degree heart block or higher.~* Patient refusal.~* On pain medication for any reason for more than 24 hrs within 2 weeks of procedure.~* Allergy to medication.~* History of alcohol or drug abuse.~* History of Cardiac/ liver/ kidney disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- dexmedetomidine (Type: EXPERIMENTAL): Experimental group will receive 1mcg/kg IV dexmedetomidine over 10 minutes intraoperatively at the beginning of surgical closure
- Normal Saline (Type: ACTIVE_COMPARATOR): Control group will receive Normal saline over 15 minutes at the beginning of surgical closure

Based on this trial design, predict the completion outcome and termination type (if applicable).